dr. Sarah Deschuymer (MD, PhD)

Topic 1: Radiotherapy in Breast Cancer
Topic 2: Radiotherapy in Head and neck cancer
 

• Increasing adherence to propylactic swallowing exercises during head end neck radiotherapy: the multicenter, randomized controlled PRESTO-trial. Dysphagia 2022 DOI: 10.1007/s00455-022-10513-6. (IF: 3.7) 
• Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma: results on the quality of life. Qual Life Res. 2020 DOI:10.1007/s11136-020-02628-w (IF: 2.39)
• Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-nec cancer patients treated with (chemo)radiotherapy (PRESTO trial). Trials 2020 DOI: 10.1186/s13063-020-4171-0 (IF: 1.98)
• Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy. Strahlenther Onkol 2020 DOI: 10.1007/s00066-020-01595-y (IF:2.7)
• Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma: update of the long-term tumor outcome. Radiother Oncol 2020 DOI: 10.1016/j.radonc.2020.01.005 (IF: 5.25)
• Benefits of deep learning for delineation of organs at risk in head and neck cancer. Radiother Oncol. 2019 DOI: 10.1016/j.radonc.2019.05.010 (IF: 4.94)
• Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality Approaches. Front Oncol, 2018 DOI: 10.3389/fonc.2018.00439 (IF: 4.42)
• Patient Selection in Human Papillomavirus Related Oropharyngeal Cancer: The added Value of Prognostic Models in the New TNM 8th edition Era. Front Oncol. 2018 DOI: 10.3389/fonc.2018.00273 (IF: 4.42)
• Clinical factors impacting on late dysphagia following radiotherapy in patients with head and neck cancer. Br J Radiol. 2018 DOI: 10.1259/bjr.20180155 (IF: 1.81)
• Validation of the total dysphagia risk score (TDRS) in head and neck cancer patients in a conventional and partially accelerated radiotherapy scheme. Radiother Oncol 2016 DOI: 101016/j.radonc.2015.10.008  *shared first authors (IF: 4.94)
   

• Lab address: Ghent University Hospital, Dept. of Radiation Oncology, 0 RTP – entrance 98, Corneel Heymanslaan 10, B-9000 Gent